In case you were wondering, an FDA advisory panel rejected Cephalon's drug Sparlon for attention deficit hyperactivity disorder or ADHD. Sparlon contains modafinil, the same ingredient in Provigil, the company's sleep-disorders drug.
TheStreet.com reports "The advisory committee voted 12-to-1 against recommending Sparlon's approval, citing its concerns about Stevens-Johnson syndrome, a rare and vicious blistering of the skin that can be caused by certain drugs. The FDA isn't bound to follow its advisers' recommendations, but it usually does so."
Posted by schwitz at March 26, 2006 09:43 AM | TrackBack